Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FUJSB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $29.67K firm fixed-price delivery order by the Defense Logistics Agency on September 15, 2025, for the supply of Entyvio 300 mg vials. The award represents a delivery order issued without set-aside designation under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500M and valid through November 2026. This delivery order will be performed at the contractor's Park Ridge, Illinois location with an ultimate completion date of October 6, 2025.
Entyvio is a biologic medication used primarily to treat inflammatory bowel diseases, and this delivery order supports the pharmaceutical supply needs of Department of Defense healthcare facilities. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its IDC with the DLA to provide various branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's established portfolio of pharmaceutical product deliveries demonstrates its capability to reliably distribute specialized medical products to government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FUJSB?
SPE2DB25FUJSB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FUJSB worth?
The government has obligated $29,670 on SPE2DB25FUJSB.
Is contract SPE2DB25FUJSB an order under another contract?
Yes. SPE2DB25FUJSB is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJSB competed?
The extent of competition for SPE2DB25FUJSB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award